Surgery for Recurrent Epithelial Ovarian Cancer

Christina Fotopoulou1, Ane Gerda Eriksson2, Itai Yagel3,4

  • 1Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK. c.fotopoulou@imperial.ac.uk.

Current Oncology Reports
|December 13, 2023
PubMed
Summary

Surgery can extend remission for carefully selected recurrent epithelial ovarian cancer (ROC) patients when combined with chemotherapy. Achieving complete tumor removal is crucial for maximizing benefits and avoiding unnecessary surgical risks.

Related Concept Videos